Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-extubational loading dose of caffeine citrate in mechanically ventilated preterm neonates
2022-003202-77Phase 4Active
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of caffeine in apnea of prematurity (AOP), extubation failure, bronchopulmonary dysplasia (BPD) and 3 more. Primary endpoint: Reintubation. Started Feb 2023; status: active.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)extubation failurebronchopulmonary dysplasia (BPD)Intraventricular hemorrhage (IVH)periventricular leukomalacia (PVL)
Beyond the preview
Go deeper on 2022-003202-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003202-77.